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Abstract
Public health strategies to reduce cardiovascular morbidity and mortality should focus on global cardiometabolic
risk reduction. The efficacy of lifestyle changes to prevent type 2 diabetes have been demonstrated, but low-cost
interventions to reduce cardiometabolic risk in Latin-America have been rarely reported. Our group developed 2
programs to promote health of high-risk individuals attending a primary care center in Brazil. This study compared
the effects of two 9-month lifestyle interventions, one based on medical consultations (traditional) and another
with 13 multi-professional group sessions in addition to the medical consultations (intensive) on cardiometabolic
parameters. Adults were eligible if they had pre-diabetes (according to the American Diabetes Association) and/or
metabolic syndrome (International Diabetes Federation criteria for Latin-America). Data were expressed as means
and standard deviations or percentages and compared between groups or testing visits. A p-value < 0.05 was
considered significant. Results: 180 individuals agreed to participate (35.0% men, mean age 54.7 ± 12.3 years, 86.1%
overweight or obese). 83 were allocated to the traditional and 97 to the intensive program. Both interventions
reduced body mass index, waist circumference and tumor necrosis factor-α. Only intensive program reduced 2-hour
plasma glucose and blood pressure and increased adiponectin values, but HDL-cholesterol increased only in the
traditional. Also, responses to programs were better in intensive compared to traditional program in terms of blood
pressure and adiponectin improvements. No new case of diabetes in intensive but 3 cases and one myocardial
infarction in traditional program were detected. Both programs induced metabolic improvement in the short-term,
but if better results in the intensive are due to higher awareness about risk and self-motivation deserves further
investigation. In conclusion, these low-cost interventions are able to minimize cardiometabolic risk factors involved
in the progression to type 2 diabetes and/or cardiovascular disease.
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Introduction
Cardiovascular disease is still a major cause of death [1]
and some data have indicated similar impact of type 2 dia-
betes mellitus (t2DM) on mortality [2]. Public health strat-
egies to reduce cardiovascular morbidity and mortality in
populations should focus on global cardiometabolic profile,
which include glucose homeostasis.
Lifestyle intervention programs to prevent t2DM have
been conducted mainly in developed countries [3,4] but
also in developing world [5]. The efficacy of a healthy
diet and physical activity has already been consistently
demonstrated and the protection conferred is higher
than that obtained by pharmacological interventions
[4-6]. Cost-effectiveness analyses have also shown the
benefits of t2DM prevention for societies [7]. Interest-
ingly, beneficial effects obtained through lifestyle
changes are observed even after the interruption of the
study protocols [8]. However, it remains a challenge for
health professionals and governmental systems to
change and sustain healthy habits in populations. Taking
these data into consideration, the International Diabetes
Federation proposed that each country should develop
your own lifestyle intervention program to improve
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health of individuals at high risk, tailored to local real-
ities [6].
In Latin America, a high prevalence of traditional car-
diovascular risk factors such as hypertension, smoking
habit and dyslipidemia are still observed, together
with the ongoing obesity and t2DM epidemic [9]. Des-
pite this scenario, few preventive programs to reduce
cardiometabolic risk in the public health system have
been developed, and low-cost interventions are urgently
needed. Effective lifestyle modification programs should
include a multi-professional team, and in this setting of
developing countries, optimizing care through interdis-
ciplinary group sessions would be desirable. Also, a lar-
ger approach, aiming at global cardiometabolic risk
reduction, would reach a higher number of individuals.
We developed two 9-month lifestyle interventions to
promote health of high-risk individuals attending a pri-
mary care center in Brazil, feasible to be implemented in
the public health system: a traditional program based on
medical consultations, and an intensive program, which
also included interdisciplinary group sessions with a
multi-professional team [10]. Such initiative may repre-
sent the first step toward orienting public health pro-
grams aimed at improving life habits of Brazilian
individuals at cardiometabolic risk.
In addition to classical cardiovascular risk factors,
identification of early metabolic disturbances is of great
importance in order to direct preventive measures. Once
inflammatory cytokines are involved in the genesis of
t2DM and atherosclerosis, markers of subclinical inflam-
mation and insulin resistance might be helpful to indi-
cate intervention benefits [11]. The present analysis
describes the impact of these intervention programs on
several cardiometabolic parameters in high-risk individ-
uals seen by the public health system in Brazil.
Methods
During 2008 and 2009, adults screened by a question-
naire of risk for t2DM were invited to a clinical examin-
ation and an oral glucose tolerance test in the School of
Public Health care unit of the University of Sao Paulo,
Brazil. These individuals, who seek for assistance under
the Brazilian public health system, predominantly have
low incomes and schooling. Inclusion criteria were age
between 18 and 79 years and the presence of prediabetic
conditions and/or metabolic syndrome without diabetes.
Individuals with a medical history of neurological or psy-
chiatric disturbances, liver, renal or infectious chronic
diseases were excluded. For this interventional study,
438 individuals were screened, 230 were eligible, 50 re-
fused to participate and 180 individuals were included in
this convenience sample (Figure 1). Among non-
participants, there was a predominance of men; however,
they did not differ from participants in terms of
sociodemographic, anthropometric or metabolic vari-
ables. This study was approved by the local Research
Ethics Committee and written consent was obtained
from all participants.
Trained staff collected physical activity, dietary and
clinical data. Body weight was measured in a digital scale
balance, height in a manual stadiometer and body mass
index (BMI) calculated. Waist circumference was mea-
sured with non-distensible tape in the upright position,
according to the WHO recommendation [12]. Blood
pressure was measured three times, in a sitting position,
by automatic device (Omron model HEM-712C, Omron
Health Care, Inc, USA). Mean of the two last measures
were considered in analyses.
Dietary data were obtained using three 24-hour recalls
and energy intake was estimated. Physical activity do-
mains were assessed by the long version of the inter-
national physical activity questionnaire [13]. The Medical
Outcome Study 36-item Short Form Health Survey
(SF-36) was used to assess quality of life, which in-
cludes questions focusing on physical and emotional
concerns of daily activities (http://www.sf-36.org).
After overnight fasting, participants were submitted to
a 75-g oral glucose tolerance test. Fasting blood samples
were collected for plasma glucose and lipid profile. Spec-
imens were aliquoted and stored at −80°C for further
Figure 1 Enrollment and follow-up.
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determinations. Categories of glucose tolerance were
defined according to the American Diabetes Association
criteria [14]. Individuals with prediabetes (impaired
fasting glycemia and/or impaired glucose tolerance)
or fulfilling metabolic syndrome criteria according to
International Diabetes Federation definition for Latin-
American populations [15] were randomly allocated to
one of the 9-month lifestyle intervention programs: the
traditional or the intensive program. At the end of the
follow-up, participants were resubmitted to the same
protocol.
In the traditional program, participants received a total
of 4 medical consultations with endocrinologist, when
counseling for changing living habits was given. In the
intensive, they attended the medical consultations plus
13 interdisciplinary group sessions, when topics on
healthy diet, physical activity and psychosocial stress
management were discussed with a multi-professional
team, including a medical doctor, nutritionist, physical
educator and psychologist. Every session was conducted
with a maximum of 15 participants and had the duration
of two hours. Six group sessions occurred during the
first two months, when strategies for changing living
habits were provided, in addition to practical informa-
tion. Thereafter, 7 monthly sessions were conducted
to reinforce compliance to the skills acquired. Also,
telephone calls between sessions aimed at enhancing
self-motivation, risk awareness and patient-professional
link. Details of the intensive program are described
elsewhere [10].
Plasma glucose was measured by the gluco-oxidase
method and lipoproteins enzymatically by automatic
analyzer. Insulin, C-reactive protein (CRP) and tumor
necrosis factor-α (TNF-α) by immunoenzymatic chemo-
luminescent assay (commercial kits for IMMULITE,
Siemens Healthcare Diagnostics Products Ltd, Llamberis,
Gwynedd, United Kingdom) and adiponectin by ELISA
(Human Adiponectin ELISA Kit, Millipore Corporation,
MA, USA). Homeostasis model assessment (HOMA-IR)
was calculated to assess insulin resistance [16].
Statistical analysis
Dietary, physical activity, clinical and laboratorial data
were expressed as means and standard deviations or
percentages. Dietary data were processed using the
Nutrition Data System® software (Minnesota Nutrition
Coordinating Center, USA). ANOVA (analysis of vari-
ance) was applied to compare mean levels of variables
between groups and testing visits (baseline and 9 months
of follow-up) and, for those variables that were different
in baseline between groups, ANCOVA (analysis of co-
variance) was applied to adjust for these differences. Per-
centages were compared by qui-square. A p-value <0.05
was considered significant. Statistics were performed
using SPSS, version 17.0 for Windows (SPSS Inc., Chicago,
Illinois, USA).
Results
From 180 individuals who agreed to participate, 83 and
97 were allocated to traditional and intensive program,
respectively (Figure 1). The main reason for refusals was
a short timeframe to attend the health care unit during
business hours. Similar proportions of individuals (22.7%
in intensive and 19.2% in the traditional, p = 0.432) were
lost to follow-up. They did not differ according to age,
sex distribution or clinical characteristics from those
who completed the intervention program.
At baseline, mean age of participants was 54.7 ±
12.3 years, 35.0% of them were men and 12.8% current
smokers. Forty-seven percent of women were post-
menopausal. A total of 86.1% were overweight or obese,
61.3% had prediabetes and 89.4% had metabolic syn-
drome. Individuals allocated to the intensive program
had higher frequency of metabolic syndrome, compared
to those to the traditional (93.8 vs. 84.3%, p < 0.05), but
they showed comparable frequencies of glucose metabol-
ism disturbances. In baseline, higher mean values of
BMI, waist circumference, and diastolic blood pressure
were observed in individuals allocated to the intensive
program, compared to those to the traditional one
(Table 1). They had also higher mean CRP and lower
adiponectin concentrations.
In the group sessions of the intensive program, mean
rate of participation was 64%. After 9 months, a higher
proportion of individuals practiced the minimum of
150 minutes of physical activity per week in inten-
sive program as compared to traditional (25.9 vs.
8.3%, p < 0.01). Energy intake reduced significantly in
both groups of interventions, but response to intensive
program was more pronounced (Table 1). Smoking habit
reductions were not observed in the intensive (14.4% of
smokers at baseline vs. 13.3% after 9 months, p = 0.896)
nor in the traditional program (10.8% of smokers at base-
line vs. 10.8% after 9 months, p = 0.999).
Both interventions induced reductions in BMI, waist
circumference and TNF-α concentration (Table 1). How-
ever, only in the intensive program, diastolic blood pres-
sure levels, 2-hour plasma glucose and adiponectin
concentrations improved significantly (Table 1). HDL-
cholesterol concentrations increased only in the trad-
itional program (Table 1).
Comparing the responses to the interventions, the in-
tensive program showed better results in terms of blood
pressure and adiponectin values (Table 1). The percent
improvement in blood pressure levels was significantly
higher in the intensive than in the traditional program
(Figure 2), as was the increase in adiponectin concentra-
tions (intensive: 51.6 vs. traditional: 6.8%, p < 0.001).
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Also, the decrease in plasma glucose levels was higher in
intensive, although difference did not reach statistical
significance (fasting plasma glucose: 4.0 in intensive vs.
1.0% in traditional, p = 0.092; 2-hour glucose: 5.8 in in-
tensive vs. 2.6% in traditional, p = 0.102). Other parame-
ters showed similar changes between groups.
No new case of t2DM was detected in intensive pro-
gram but three in the traditional during the follow-up
and one non-fatal myocardial infarction occurred among
individuals from the traditional program.
Discussion
This real-life prevention study showed that 9-month life-
style interventions in high-risk adults treated under the
public health system of a developing country were able
to change their cardiometabolic risk profile. This is of
great interest since our low-cost interventions [10] may
be useful for Brazilian public health system and for other
countries with similar realities. Our findings are in
agreement with previous efficacy trials, in which lifestyle
modifications were associated with diabetes prevention
[2-4]. In comparison to a doctor-centered intervention
(traditional program), an interdisciplinary approach con-
sidering also psychosocial aspects of the individuals may
result in better outcomes in the long term.
In research setting, trials on t2DM prevention
conducted in developed world [3,4] and other develop-
ing countries [5] proved the efficacy of lifestyle interven-
tion programs. Noteworthy, the Indian experience [5],
tailored to middle-class population, showed a lower cu-
mulative incidence of diabetes in the intensive interven-
tion, when compared to the control group, after 3 years
of follow-up (55.0% vs. 39.3%; p < 0.05). Afterwards,
International Diabetes Federation have encouraged the
development of t2DM preventive programs, and realistic
Table 1 Baseline and 9-month clinical and laboratory data and their changes according to the type of intervention
(IP: intensive and TP: traditional)
Intensive Traditional p
(intensive
vs.
traditional)
Baseline 9 months p Baseline 9 months p
Energy intake (kcal) 1870 ± 77 1519 ± 64 <0.001 1735 ± 83 1539 ± 70 <0.001 0.043
Body mass index (kg/m2) 31.7 ± 5.7 31.0 ± 5.7 <0.001 29.9 ± 5.8** 29.4 ± 5.4** 0.002 0.510
Waist circumference (cm) 103.6 ± 11.9 101.0 ± 10.7 <0.001 98.6 ± 13.5** 97.3 ± 12.8** 0.036 0.053
Systolic blood pressure (mmHg) 136.3 ± 17.4 132.2 ± 19.1 0.060 134.3 ± 17.8 134.7 ± 18.9 0.994 0.037
Diastolic blood pressure (mmHg) 84.2 ± 10.0 79.6 ± 8.5 <0.001 80.3 ± 9.9** 79.7 ± 8.1 0.933 <0.001
Fasting plasma glucose (mg/dL) 99.4 ± 12.1 96.7 ± 12.1 0.072 99.1 ± 11.0 98.4 ± 12.8 0.646 0.262
2-h plasma glucose (mg/dL) 121.2 ± 27.6 114.1 ± 28.5 0.047 115.1 ± 26.9 114.2 ± 30.3 0.991 0.088
Fasting insulin (μUI/mL) 10.4 ± 6.9 8.8 ± 6.7 0.089 9.9 ± 6.8 7.8 ± 5.9 0.019 0.569
HOMA-IR 2.55 ± 1.75 2.10 ± 1.61 0.059 2.44 ± 1.79 1.96 ± 1.65 0.059 0.904
Total cholesterol (mg/dL) 201.8 ± 39.8 197.6 ± 39.9 0.258 195.9 ± 44.6 193.6 ± 46.9 0.370 0.748
HDL-cholesterol (mg/dL) 42.7 ± 11.8 45.5 ± 12.6 0.058 41.7 ± 11.8 45.3 ± 12.3 0.011 0.563
Triglycerides (mg/dL) 151.4 ± 66.5 144.7 ± 51.6 0.568 150.4 ± 68.4 152.7 ± 87.8 0.725 0.245
Adiponectin (ng/mL) 11.6 ± 7.2 15.7 ± 9.7 0.018 18.1 ± 17.6** 18.2 ± 17.1 0.999 0.030
TNF-α (ng/mL) 12.6 ± 6.2 11.0 ± 7.2 0.017 12.4 ± 7.2 10.6 ± 5.3 0.004 0.634
C-reactive protein (mg/dL) 0.60 ± 0.56 0.58 ± 0.56 0.963 0.42 ± 0.49** 0.30 ± 0.34** 0.084 0.132
Data expressed as means and standard deviations.
Statistical analysis: repeated measures ANOVA or ANCOVA.
* p < 0.05; **p < 0.001 vs. intensive.
BMI: body mass index; WC: waist circumference; TNF: tumor necrosis factor.
Figure 2 Percent changes in blood pressure (SBP: systolic; DBP:
diastolic blood pressure) during 9 months of follow up,
according to the intervention program: IP (intensive) and TP
(traditional program).
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interventions have been implemented in Europe through
the DE-Plan (Diabetes in Europe: Prevention using Life-
style, Physical Activity and Nutritional intervention Pro-
ject) and the IMAGE project [17,18].
Trying to meet these IDF recommendations, we devel-
oped two modalities of intervention and compared them
in the short-term: a traditional, based on medical consul-
tations with endocrinologist, and an intensive, which
also had the interdisciplinary group sessions. Both were
effective to reduce energy intake, BMI and waist circum-
ference, and even though these were modest changes, a
beneficial impact on cardiometabolic risk factors could
be observed. Our patients allocated to the intensive pro-
gram showed a more severe metabolic condition, but
apart from worse baseline characteristics, they showed
greater benefits compared with the traditional, reinfor-
cing the role of the multiprofessional team and group
approach in changing living habits.
Intensive program was more effective than the trad-
itional one to reduce blood pressure levels. These
findings were mostly attributed to improvements in
compliance with anti-hypertensive medication, possibly as
a consequence of higher awareness about their risks. Sys-
temic hypertension is an important cardiometabolic risk
factor, so this result has the potential to impact mortality
rates in the long term. Analysis of a program implemented
in Greek population, with the purpose of preventing
t2DM in the clinical setting, also found improvement in
systolic blood pressure as a secondary goal [19].
The pathogenetic role of adipocytokines as mediators
of obesity-induced insulin resistance and promoters of
endothelial dysfunction predisposing individuals to ath-
erosclerosis has been demonstrated [11]. In contrast,
adiponectin is shown to improve insulin sensitivity and
its concentration is lower in obese than in lean subjects
[20]. In our study, even a modest weight loss, induced
by changes in diet and physical activity, was capable to
improve biomarkers of insulin resistance in the short-
term. After 9 months of follow-up, our sample obtained
favorable changes in TNF-α and adiponectin concen-
trations which may have triggered HOMA-IR reduc-
tions. Additionally, the intensive program showed to
be more effective to promote the desirable elevation
in adiponectin. We speculate that these benefits could
translate into reductions in t2DM and cardiovascular
disease incidence in the long-term.
Similar to our intervention, the GOAL trial implemented
a low-cost lifestyle intervention to prevent t2DM [21]. Indi-
viduals at high cardiometabolic risk were submitted to 6
group sessions, in which counseling for changing living
habits were given by a nurse during a period of 8 months.
In contrast, our approach had a higher number of sessions
and involved a multiprofessional team, including a psych-
ologist focusing on emotional aspects. In the GOAL trial,
the conversion rate to t2DM after 3 years was 12%, an
intermediate value between 9% obtained in the intensive
intervention and 20% in the control group of the Diabetes
Prevention Study [3]. In our study, after 9 months, only
three patients from the traditional program progressed
to DM and none in the intensive. Although the short
duration of our study and sample size did not allow
assessing incidence rates, this result may anticipate a
protective effect.
The rate of participation on group sessions (64%) was
considered satisfactory, provided that patients were
adults and sessions were conducted during the business
hours. We speculate that the presence of a mental health
professional in the team improved compliance, once psy-
chiatric disorders are known to interfere with treatment
outcomes [22]. Also, our group has already reported im-
provements in quality of life in those who participated in
the intensive program: role-emotional domain of SF-36
improved in intensive but not in traditional program;
and in addition, some positive changes in domains of
quality of life correlated to better metabolic outcomes
[23]. These results could have impacted self-motivation
to adhere with lifestyle changes proposed during the
group sessions.
Our study has some limitations. The small sample size
and short duration of follow-up did not allow analysis of
t2DM or cardiovascular events incidence. Extrapolation
to other populations from other developing countries is
not possible, but could be tested. At last, it is note-
worthy that our reference group was not an ideal control
group, considering that medical consultation with an
endocrinologist is not commonly available in primary
care units. This could have somehow limited the detec-
tion of more pronounced differences between modalities
of interventions, minimizing the real impact of the in-
tensive intervention in changing living habits.
In summary, both programs, developed to reduce
cardiometabolic risk of individuals attending public
health system in Brazil, improved metabolic status in the
short-term, and the multiprofessional team and group
approach induced some better results. We call attention
to the potential of these low-cost interventions, feasible
in the clinical setting, to promote health of high-risk in-
dividuals and maybe slow their progression to t2DM
and/or cardiovascular disease.
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